Found: 57
Select item for more details and to access through your institution.
Should Human Immunodeficiency Virus Testing Be Replaced With Combined Blood-Borne Virus Testing?
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 2, p. 1, doi. 10.1093/ofid/ofad668
- By:
- Publication type:
- Article
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 10, p. 1423, doi. 10.1093/cid/ciad370
- By:
- Publication type:
- Article
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2023, v. 18, n. 7, p. 1, doi. 10.1371/journal.pone.0288598
- By:
- Publication type:
- Article
Public understanding and awareness of and response to monkeypox virus outbreak: A cross‐sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency.
- Published in:
- HIV Medicine, 2023, v. 24, n. 5, p. 544, doi. 10.1111/hiv.13430
- By:
- Publication type:
- Article
MPOX IN PEOPLE LIVING WITH HIV AND CD4 COUNTS < 350 CELLS/MM3: A GLOBAL CASE SERIES.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 71
- By:
- Publication type:
- Article
TARGET3D: GLECAPREVIR-PIBRENTASVIR FOR FOUR WEEKS IN PEOPLE WITH RECENT HCV INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 80
- By:
- Publication type:
- Article
Hospitalization risk among patients with Mpox infection—a propensity score matched analysis.
- Published in:
- Therapeutic Advances in Infectious Disease, 2023, v. 10, p. 1, doi. 10.1177/20499361231196683
- By:
- Publication type:
- Article
BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.
- Published in:
- HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
- By:
- Publication type:
- Article
LONG-TERM INTEGRATED ANALYSIS OF B/F/TAF IN TREATMENT-NAÏVE ADULTS WITH HIV THROUGH FIVE YEARS OF FOLLOW-UP.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 283
- By:
- Publication type:
- Article
Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV.
- Published in:
- HIV Medicine, 2022, v. 23, n. 9, p. 936, doi. 10.1111/hiv.13288
- By:
- Publication type:
- Article
B/F/TAF five-year outcomes in treatment-naïve adults.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S313
- By:
- Publication type:
- Article
Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir.
- Published in:
- HIV Medicine, 2022, v. 23, n. 4, p. 362, doi. 10.1111/hiv.13215
- By:
- Publication type:
- Article
Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi‐centre analysis (RECEDE‐C19 study).
- Published in:
- HIV Medicine, 2022, v. 23, n. 2, p. 121, doi. 10.1111/hiv.13174
- By:
- Publication type:
- Article
Acute kidney injury in COVID-19: multicentre prospective analysis of registry data.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 11, p. 2356, doi. 10.1093/ckj/sfab071
- By:
- Publication type:
- Article
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1440, doi. 10.1093/cid/ciab444
- By:
- Publication type:
- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. 33, doi. 10.1093/cid/ciaa822
- By:
- Publication type:
- Article
Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 2, p. 233, doi. 10.1093/cid/ciaa021
- By:
- Publication type:
- Article
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 6, p. 1379, doi. 10.1093/cid/ciz999
- By:
- Publication type:
- Article
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa202
- By:
- Publication type:
- Article
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus–1: An Integrated Safety Analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1336, doi. 10.1093/cid/ciz423
- By:
- Publication type:
- Article
Once-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1344, doi. 10.1093/cid/ciz424
- By:
- Publication type:
- Article
Reply to Lanzafame et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study.
- Published in:
- AIDS Research & Therapy, 2019, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12981-019-0235-1
- By:
- Publication type:
- Article
Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 27, p. 1, doi. 10.2807/1560-7917.ES.2019.24.27.1800377
- By:
- Publication type:
- Article
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 535, doi. 10.1093/cid/ciy540
- By:
- Publication type:
- Article
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 7, p. 1010, doi. 10.1093/cid/ciy220
- By:
- Publication type:
- Article
Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.
- Published in:
- AIDS Research & Therapy, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12981-018-0198-7
- By:
- Publication type:
- Article
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx154
- By:
- Publication type:
- Article
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 10, p. 1413, doi. 10.1093/cid/cix167
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
- Published in:
- HIV Medicine, 2016, v. 17, p. s2, doi. 10.1111/hiv.12426
- By:
- Publication type:
- Article
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 3, p. 367, doi. 10.1093/infdis/jiv005
- By:
- Publication type:
- Article
A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0116297
- By:
- Publication type:
- Article
Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 11, p. 1579, doi. 10.1093/cid/ciu675
- By:
- Publication type:
- Article
Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1-Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis.
- Published in:
- AIDS Patient Care & STDs, 2014, v. 28, n. 4, p. 168, doi. 10.1089/apc.2013.0310
- By:
- Publication type:
- Article
Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1-Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
British HIV Association guidelines for HIV-associated malignancies 2014.
- Published in:
- HIV Medicine, 2014, v. 15, p. 1, doi. 10.1111/hiv.12185
- By:
- Publication type:
- Article
British HIV Association guidelines for HIV-associated malignancies 2014.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).
- Published in:
- HIV Medicine, 2014, v. 15, p. 1, doi. 10.1111/hiv.12119
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.
- Published in:
- HIV Medicine, 2013, v. 14, p. 1, doi. 10.1111/hiv.12106
- By:
- Publication type:
- Article
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1354
- By:
- Publication type:
- Article
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061949
- By:
- Publication type:
- Article
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.
- Published in:
- AIDS Research & Therapy, 2013, v. 10, p. 5, doi. 10.1186/1742-6405-10-5
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.
- Published in:
- HIV Medicine, 2012, v. 13, p. 1, doi. 10.1111/j.1468-1293.2012.01029.x
- By:
- Publication type:
- Article
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 4, p. 353, doi. 10.1001/jama.2012.6936
- By:
- Publication type:
- Article
Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 4, p. 540, doi. 10.1093/infdis/jir380
- By:
- Publication type:
- Article